{"id":36560,"date":"2026-01-06T14:41:48","date_gmt":"2026-01-06T13:41:48","guid":{"rendered":"https:\/\/www.hollandbio.nl\/?p=36560"},"modified":"2026-01-08T13:51:09","modified_gmt":"2026-01-08T12:51:09","slug":"nederlandse-biotechsector-blinkt-uit","status":"publish","type":"post","link":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/","title":{"rendered":"Nederlandse biotech sector blinkt uit"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Uit de <a href=\"https:\/\/fd.nl\/tech-en-innovatie\/1581738\/nederlandse-biotechbedrijven-blinken-opnieuw-uit-onder-aanvoering-van-merus?gift=UF2PN&amp;utm_medium=social&amp;utm_source=link&amp;utm_campaign=earned&amp;utm_content=20260105\">oranje biotechindex<\/a> van het Financieele Dagblad blijkt dat Nederlandse beursgenoteerde biotechbedrijven tot de wereldtop behoren. De zes Nederlandse biotechfondsen presteerden met een gemiddelde koerswinst van maar liefst 37% in 2025 ruim boven de AEX \u00e9n internationale benchmarks als de Nasdaq Biotech Index (17%). Uitschieters als Merus (+114%, dankzij de overname door Genmab), Pharming (+54%), Uniqure (+36%) en NewAmsterdam Pharma (+37%) bewijzen dat Nederlandse biotech internationaal meetelt en investeerders weet te overtuigen. Wat zijn de kansen voor 2026?<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Deze topprestaties zijn geen toeval: Nederland blinkt uit in innovatie, met&nbsp;<a href=\"https:\/\/www.oecd.org\/content\/dam\/oecd\/en\/publications\/reports\/2025\/12\/country-health-profile-2025-country-notes_7e72146d\/netherlands_a535bf5a\/95a85df5-en.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">twee keer zoveel internationale patentaanvragen en klinische trials per hoofd van de bevolking<\/a>&nbsp;als het EU-gemiddelde.&nbsp;De sector is wereldwijd zichtbaar, maar de groep beursgenoteerde bedrijven krimpt door overnames en het<a href=\"https:\/\/www.nu.nl\/economie\/6381676\/biotechbedrijf-galapagos-stopt-met-celtherapie-en-sluit-nederlandse-vestiging.html\" target=\"_blank\" rel=\"noreferrer noopener\">&nbsp;vertrek van spelers als Galapagos<\/a>.&nbsp;Nieuwe aanwas is dus cruciaal om de zichtbaarheid en het verdienvermogen op peil te houden.&nbsp;&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">De internationale&nbsp;biotechmarkt&nbsp;biedt volop kansen.&nbsp;De sector herstelt sterk, investeerders zoeken naar onderscheidende innovatie en&nbsp;<a href=\"https:\/\/www.biospace.com\/business\/with-biotech-back-analysts-make-their-picks-for-2026?utm_term=2894CB4D-7133-4649-B19A-786D6CDA7E1A&amp;lrh=0592c31c9bf997c30bb7cb930bfc985419c21f9a5f8090d6061fb674a5ab3e8c&amp;utm_campaign=D4C8EBAD-9C67-4D55-869C-CC2C8F893F9E&amp;utm_medium=email&amp;utm_content=789B4156-FBC6-4FA1-A281-E72A9AFEF149&amp;utm_source=SmartBrief\" target=\"_blank\" rel=\"noreferrer noopener\">2026 belooft een topjaar te worden<\/a>&nbsp;voor fusies en overnames.&nbsp;Therapeutische domeinen als obesitas&nbsp;en&nbsp;Alzheimer&nbsp;en cel- en&nbsp;gentherapie\u00ebn&nbsp;staan volop in de belangstelling. Tegelijkertijd blijft het zaak om scherp te blijven op regelgeving, concurrentie en toegang tot kapitaal.&nbsp;<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Het momentum is nu: Nederland heeft alles in huis om door te pakken. Structurele investeringen, een integrale strategie en optimale randvoorwaarden \u2013 van technologieoverdracht tot data-infrastructuur \u2013 zijn essentieel om de economische en maatschappelijke potentie van&nbsp;biotech&nbsp;volledig te benutten. De rode loper ligt uit, de seinen staan op groen: tijd om gas te geven en de internationale&nbsp;biotechmarkt&nbsp;te veroveren!&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Uit de oranje biotechindex van het Financieele Dagblad blijkt dat Nederlandse beursgenoteerde biotechbedrijven tot de wereldtop behoren. De zes Nederlandse biotechfondsen presteerden met een gemiddelde koerswinst van maar liefst 37% in 2025 ruim boven de AEX \u00e9n internationale benchmarks als de Nasdaq Biotech Index (17%). Uitschieters als Merus (+114%, dankzij de overname door Genmab), Pharming [&hellip;]<\/p>\n","protected":false},"author":24,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[43],"tags":[],"class_list":["post-36560","post","type-post","status-publish","format-standard","hentry","category-innovatieklimaat"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nederlandse biotech sector blinkt uit - hollandbio<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nederlandse biotech sector blinkt uit - hollandbio\" \/>\n<meta property=\"og:description\" content=\"Uit de oranje biotechindex van het Financieele Dagblad blijkt dat Nederlandse beursgenoteerde biotechbedrijven tot de wereldtop behoren. De zes Nederlandse biotechfondsen presteerden met een gemiddelde koerswinst van maar liefst 37% in 2025 ruim boven de AEX \u00e9n internationale benchmarks als de Nasdaq Biotech Index (17%). Uitschieters als Merus (+114%, dankzij de overname door Genmab), Pharming [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/\" \/>\n<meta property=\"og:site_name\" content=\"hollandbio\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-06T13:41:48+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-01-08T12:51:09+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"675\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Idalia Dlugosz\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:site\" content=\"@hollandbio\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Idalia Dlugosz\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederlandse-biotechsector-blinkt-uit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederlandse-biotechsector-blinkt-uit\\\/\"},\"author\":{\"name\":\"Idalia Dlugosz\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/20e3aa22ca991fdb93f4c843c0c0099c\"},\"headline\":\"Nederlandse biotech sector blinkt uit\",\"datePublished\":\"2026-01-06T13:41:48+00:00\",\"dateModified\":\"2026-01-08T12:51:09+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederlandse-biotechsector-blinkt-uit\\\/\"},\"wordCount\":277,\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"articleSection\":[\"Innovatieklimaat\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederlandse-biotechsector-blinkt-uit\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederlandse-biotechsector-blinkt-uit\\\/\",\"name\":\"Nederlandse biotech sector blinkt uit - hollandbio\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\"},\"datePublished\":\"2026-01-06T13:41:48+00:00\",\"dateModified\":\"2026-01-08T12:51:09+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederlandse-biotechsector-blinkt-uit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederlandse-biotechsector-blinkt-uit\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/nieuws\\\/nederlandse-biotechsector-blinkt-uit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Nederlandse biotech sector blinkt uit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"name\":\"hollandbio\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#organization\",\"name\":\"hollandbio\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.hollandbio.nl\\\/wp-content\\\/uploads\\\/2023\\\/08\\\/HollandBIO_logo.svg\",\"width\":218.664,\"height\":29.659,\"caption\":\"hollandbio\"},\"image\":{\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/hollandbio\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/hollandbio\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.hollandbio.nl\\\/en\\\/#\\\/schema\\\/person\\\/20e3aa22ca991fdb93f4c843c0c0099c\",\"name\":\"Idalia Dlugosz\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nederlandse biotech sector blinkt uit - hollandbio","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/","og_locale":"en_US","og_type":"article","og_title":"Nederlandse biotech sector blinkt uit - hollandbio","og_description":"Uit de oranje biotechindex van het Financieele Dagblad blijkt dat Nederlandse beursgenoteerde biotechbedrijven tot de wereldtop behoren. De zes Nederlandse biotechfondsen presteerden met een gemiddelde koerswinst van maar liefst 37% in 2025 ruim boven de AEX \u00e9n internationale benchmarks als de Nasdaq Biotech Index (17%). Uitschieters als Merus (+114%, dankzij de overname door Genmab), Pharming [&hellip;]","og_url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/","og_site_name":"hollandbio","article_published_time":"2026-01-06T13:41:48+00:00","article_modified_time":"2026-01-08T12:51:09+00:00","og_image":[{"width":1200,"height":675,"url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2025\/01\/hb-opengraph_illu.png","type":"image\/png"}],"author":"Idalia Dlugosz","twitter_card":"summary_large_image","twitter_creator":"@hollandbio","twitter_site":"@hollandbio","twitter_misc":{"Written by":"Idalia Dlugosz","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/#article","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/"},"author":{"name":"Idalia Dlugosz","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/20e3aa22ca991fdb93f4c843c0c0099c"},"headline":"Nederlandse biotech sector blinkt uit","datePublished":"2026-01-06T13:41:48+00:00","dateModified":"2026-01-08T12:51:09+00:00","mainEntityOfPage":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/"},"wordCount":277,"publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"articleSection":["Innovatieklimaat"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/","url":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/","name":"Nederlandse biotech sector blinkt uit - hollandbio","isPartOf":{"@id":"https:\/\/www.hollandbio.nl\/en\/#website"},"datePublished":"2026-01-06T13:41:48+00:00","dateModified":"2026-01-08T12:51:09+00:00","breadcrumb":{"@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.hollandbio.nl\/en\/nieuws\/nederlandse-biotechsector-blinkt-uit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.hollandbio.nl\/en\/"},{"@type":"ListItem","position":2,"name":"Nederlandse biotech sector blinkt uit"}]},{"@type":"WebSite","@id":"https:\/\/www.hollandbio.nl\/en\/#website","url":"https:\/\/www.hollandbio.nl\/en\/","name":"hollandbio","description":"","publisher":{"@id":"https:\/\/www.hollandbio.nl\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.hollandbio.nl\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.hollandbio.nl\/en\/#organization","name":"hollandbio","url":"https:\/\/www.hollandbio.nl\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","contentUrl":"https:\/\/www.hollandbio.nl\/wp-content\/uploads\/2023\/08\/HollandBIO_logo.svg","width":218.664,"height":29.659,"caption":"hollandbio"},"image":{"@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/hollandbio","https:\/\/www.linkedin.com\/company\/hollandbio\/"]},{"@type":"Person","@id":"https:\/\/www.hollandbio.nl\/en\/#\/schema\/person\/20e3aa22ca991fdb93f4c843c0c0099c","name":"Idalia Dlugosz"}]}},"_links":{"self":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/36560","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/comments?post=36560"}],"version-history":[{"count":4,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/36560\/revisions"}],"predecessor-version":[{"id":36584,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/posts\/36560\/revisions\/36584"}],"wp:attachment":[{"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/media?parent=36560"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/categories?post=36560"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.hollandbio.nl\/en\/wp-json\/wp\/v2\/tags?post=36560"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}